Searle & Co’s Quest Diagnostics DGX Stock Holding History

Searle & Co’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$530K	Hold	2,500	–	–	0.12%	118
2026 Q1	$490K	Hold	2,500	–	–	0.12%	122
2025 Q4	$434K	Hold	2,500	–	–	0.11%	123
2025 Q3	$476K	Hold	2,500	–	–	0.13%	119
2025 Q2	$449K	Hold	2,500	–	–	0.13%	118
2025 Q1	$423K	Hold	2,500	–	–	0.12%	118
2024 Q4	$377K	Hold	2,500	–	–	0.11%	127
2024 Q3	$388K	Hold	2,500	–	–	0.1%	118
2024 Q2	$342K	Hold	2,500	–	–	0.08%	134
2024 Q1	$333K	Hold	2,500	–	–	0.08%	123
2023 Q4	$345K	Hold	2,500	–	–	0.09%	119
2023 Q3	$305K	Hold	2,500	–	–	0.1%	116
2023 Q2	$338K	Hold	2,500	–	–	0.1%	117
2023 Q1	$347K	Hold	2,500	–	–	0.11%	115
2022 Q4	$391K	Hold	2,500	–	–	0.13%	110
2022 Q3	$307K	Hold	2,500	–	–	0.12%	121
2022 Q2	$332K	Hold	2,500	–	–	0.13%	119
2022 Q1	$342K	Hold	2,500	–	–	0.13%	124
2021 Q4	$433K	Hold	2,500	–	–	0.16%	108
2021 Q3	$363K	Hold	2,500	–	–	0.15%	111
2021 Q2	$330K	Hold	2,500	–	–	0.14%	113
2021 Q1	$321K	Hold	2,500	–	–	0.14%	112
2020 Q4	$298K	Hold	2,500	–	–	0.14%	110
2020 Q3	$286K	Hold	2,500	–	–	0.16%	109
2020 Q2	$285K	Hold	2,500	–	–	0.17%	105
2020 Q1	$201K	Hold	2,500	–	–	0.14%	113
2019 Q4	$267K	Hold	2,500	–	–	0.15%	115
2019 Q3	$268K	Hold	2,500	–	–	0.16%	109
2019 Q2	$255K	Hold	2,500	–	–	0.16%	112
2019 Q1	$225K	Hold	2,500	–	–	0.14%	119
2018 Q4	$208K	Hold	2,500	–	–	0.15%	115
2018 Q3	$270K	Hold	2,500	–	–	0.16%	113
2018 Q2	$275K	Hold	2,500	–	–	0.17%	111
2018 Q1	$251K	Hold	2,500	–	–	0.16%	118
2017 Q4	$246K	Hold	2,500	–	–	0.15%	120
2017 Q3	$234K	Hold	2,500	–	–	0.15%	116
2017 Q2	$278K	Hold	2,500	–	–	0.19%	115
2017 Q1	$245K	Hold	2,500	–	–	0.17%	119
2016 Q4	$230K	Hold	2,500	–	–	0.19%	108
2016 Q3	$209K	Buy	+2,500	New	+$210K	0.18%	109
2015 Q3	–	Sell	-2,500	Closed	-$181K	–	139
2015 Q2	$181K	Hold	2,500	–	–	0.15%	109
2015 Q1	$192K	Hold	2,500	–	–	0.17%	103
2014 Q4	$167K	Buy	+2,500	New	+$158K	0.14%	118

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Searle & Co's DGX Position: Q2 2026 in Review

Searle & Co held its Quest Diagnostics (DGX) position steady in Q2 2026 at 2,500 shares worth $530K. The position accounts for 0.12% of the portfolio, ranked #118.

Searle & Co first reported a position in DGX in Q4 2014 and has held it in 43 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Searle & Co held 2,500 shares of Quest Diagnostics worth $530K as of Q2 2026.
Searle & Co left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.12% of Searle & Co's portfolio in Q2 2026, its #118 holding.
Searle & Co first reported a position in Quest Diagnostics in Q4 2014 and has held it in 43 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Searle & Co's 13F filing for Q2 2026, filed 27 Jul 2026.